Literature DB >> 22826337

Genetic diversity as a marker for timing infection in HIV-infected patients: evaluation of a 6-month window and comparison with BED.

Manon Ragonnet-Cronin1, Stéphane Aris-Brosou, Isabelle Joanisse, Harriet Merks, Dominic Vallée, Kyna Caminiti, Michael Rekart, Mel Krajden, Darrel Cook, John Kim, Laurie Malloch, Paul Sandstrom, James Brooks.   

Abstract

BACKGROUND: It has been reported that the increase in human immunodeficiency virus (HIV) sequence diversity in drug resistance surveillance specimens may be used to classify the duration of HIV infection as <1 or >1 year. We describe a mixed base classifier (MBC) optimized to categorize the duration of subtype B infections as <6 or >6 months on the basis of sequences for drug resistance surveillance specimens and compared MBC findings with those of serologic methods.
METHODS: The behavior of the MBC was examined across a range of thresholds for calling mixed bases. MBC performance was then evaluated using either complete pol sequences or sites reflecting evolutionary pressures (HLA selection sites, sites that increased in entropy over the course of infection, and codon positions).
RESULTS: The MBC performance was optimal when secondary peaks on the sequencing chromatogram accounted for at least 15% of the area of primary peaks. A cutoff of <0.45% mixed bases in the pol region best identified recent infections (sensitivity = 82.7%, specificity = 78.8%), with improvement achieved by analyzing only sites that increased in entropy.
CONCLUSIONS: In an extended data set of 1354 specimens classified by BED, the optimized MBC performed significantly better than a simple MBC (agreement, 68.98% vs 67.13%). If further validated, the MBC may prove beneficial for detecting recent infection and estimating the incidence of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22826337     DOI: 10.1093/infdis/jis411

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  Strengthening HIV surveillance: measurements to track the epidemic in real time.

Authors:  Usangiphile E Buthelezi; Candace L Davidson; Ayesha Bm Kharsany
Journal:  Afr J AIDS Res       Date:  2016-07       Impact factor: 1.300

2.  Ten years survey of primary HIV-1 resistance in Serbia: the occurrence of multiclass resistance.

Authors:  Maja Stanojevic; Marina Siljic; Dubravka Salemovic; Ivana Pesic-Pavlovic; Sonja Zerjav; Valentina Nikolic; Jovan Ranin; Djordje Jevtovic
Journal:  AIDS Res Hum Retroviruses       Date:  2014-04-09       Impact factor: 2.205

3.  Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studies.

Authors:  Karolin Meixenberger; Andrea Hauser; Klaus Jansen; Kaveh Pouran Yousef; Stefan Fiedler; Max von Kleist; Stephen Norley; Sybille Somogyi; Osamah Hamouda; Norbert Bannert; Barbara Bartmeyer; Claudia Kücherer
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

Review 4.  How can we better identify early HIV infections?

Authors:  Nora E Rosenberg; Christopher D Pilcher; Michael P Busch; Myron S Cohen
Journal:  Curr Opin HIV AIDS       Date:  2015-01       Impact factor: 4.283

5.  Trends of HIV-1 incidence with credible intervals in Sweden 2002-09 reconstructed using a dynamic model of within-patient IgG growth.

Authors:  Ethan Obie Romero-Severson; Cody Lee Petrie; Edward Ionides; Jan Albert; Thomas Leitner
Journal:  Int J Epidemiol       Date:  2015-07-10       Impact factor: 7.196

6.  Determinants of HIV-1 broadly neutralizing antibody induction.

Authors:  Peter Rusert; Roger D Kouyos; Claus Kadelka; Hanna Ebner; Merle Schanz; Michael Huber; Dominique L Braun; Nathanael Hozé; Alexandra Scherrer; Carsten Magnus; Jacqueline Weber; Therese Uhr; Valentina Cippa; Christian W Thorball; Herbert Kuster; Matthias Cavassini; Enos Bernasconi; Matthias Hoffmann; Alexandra Calmy; Manuel Battegay; Andri Rauch; Sabine Yerly; Vincent Aubert; Thomas Klimkait; Jürg Böni; Jacques Fellay; Roland R Regoes; Huldrych F Günthard; Alexandra Trkola
Journal:  Nat Med       Date:  2016-09-26       Impact factor: 53.440

7.  Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys.

Authors:  Emmi Andersson; Wei Shao; Irene Bontell; Fatim Cham; Do Duy Cuong; Amogne Wondwossen; Lynn Morris; Gillian Hunt; Anders Sönnerborg; Silvia Bertagnolio; Frank Maldarelli; Michael R Jordan
Journal:  Infect Genet Evol       Date:  2013-04-11       Impact factor: 3.342

8.  Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.

Authors:  Yen T Duong; Reshma Kassanjee; Alex Welte; Meade Morgan; Anindya De; Trudy Dobbs; Erin Rottinghaus; John Nkengasong; Marcel E Curlin; Chonticha Kittinunvorakoon; Boonyos Raengsakulrach; Michael Martin; Kachit Choopanya; Suphak Vanichseni; Yan Jiang; Maofeng Qiu; Haiying Yu; Yan Hao; Neha Shah; Linh-Vi Le; Andrea A Kim; Tuan Anh Nguyen; William Ampofo; Bharat S Parekh
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

9.  Invasion history and demographic pattern of Cryphonectria hypovirus 1 across European populations of the chestnut blight fungus.

Authors:  Sarah F Bryner; Daniel Rigling; Patrick C Brunner
Journal:  Ecol Evol       Date:  2012-11-22       Impact factor: 2.912

10.  Towards estimation of HIV-1 date of infection: a time-continuous IgG-model shows that seroconversion does not occur at the midpoint between negative and positive tests.

Authors:  Helena Skar; Jan Albert; Thomas Leitner
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.